Skip to main content

Advertisement

Log in

Determination of ocfentanil and W-18 in a suspicious heroin-like powder in Belgium

  • Case Report
  • Published:
Forensic Toxicology Aims and scope Submit manuscript

Abstract

Purpose

Since the early 2010s, synthetic opioids have been on the rise in the illicit drug markets of North America and Europe, often as adulterants or substitutes for heroin. Ocfentanil, an early-onset fentanyl analogue, has been implicated in several fatalities, predominantly in Europe. W-18 is more prevalent in Canada and the United States. We present the findings for an unknown brown powder, advertised and purchased as heroin, which was sent to our laboratory for analysis in the framework of the Belgian Early Warning System on Drugs.

Methods

The sample was screened using liquid chromatograph coupled to a diode array detector and gas chromatograph coupled to a single quadrupole mass spectrometer. The findings were confirmed by liquid chromatography—triple quadrupole mass spectrometry.

Results

No heroin, 6-monoacetylmorphine or morphine was detected. Our analysis detected two new psychoactive substances: the synthetic opioid ocfentanil (1.6% m/m), and W-18 (0.3% m/m). The ocfentanil concentration was similar to those found in previous reports. No reference concentrations have been published for W-18. The presence of these two new psychoactive substances together in the same powder is unprecedented and prompted a warning by the Belgian Early Warning System on Drugs.

Conclusion

The unknown powder tested positive for ocfentanil and W-18. To the authors’ best knowledge this is the first case of the combined detection of these two new psychoactive substances in the same powder. We additionally demonstrate the advantage of building an in-house reference library beyond retention time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CSL:

Cayman Spectral Library

dMRM:

Dynamic multiple reaction monitoring

DAD:

Diode array detector

GC:

Gas chromatography

LC:

Liquid chromatography

MS:

Mass spectrometry

QQQ:

Triple quadrupole mass spectrometer

RT:

Retention time

References

  1. European Monitoring Centre for Drugs and Drug Addiction (2018) Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation—an update from the EU Early Warning System. Publications Office of the European Union, Luxembourg

    Google Scholar 

  2. Rudd RA, Seth P, David F, Scholl L (2016) Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. US Department of Health and Human Services / Centers for Disease Control and Prevention, Atlanta

    Book  Google Scholar 

  3. United Nations Office on Drugs and Crime (2017) Fentanyl and its analogues—50 years on. Global Smart Update, Vienna

    Google Scholar 

  4. European Monitoring Centre for Drugs and Drug Addiction (2018) European drug report 2018: trends and developments. Publications Office of the European Union, Luxembourg

    Google Scholar 

  5. Allibe N, Richeval C, Phanithavong M et al (2018) Fatality involving ocfentanil documented by identification of metabolites. Drug Test Anal 10:995–1000. https://doi.org/10.1002/dta.2326

    Article  CAS  PubMed  Google Scholar 

  6. Zawilska JB (2017) An expanding world of novel psychoactive substances: opioids. Front Psychiatry 8:110. https://doi.org/10.3389/fpsyt.2017.00110

    Article  PubMed  PubMed Central  Google Scholar 

  7. Coopman V, Cordonnier J, De Leeuw M, Cirimele V (2016) Ocfentanil overdose fatality in the recreational drug scene. Forensic Sci Int 266:469–473. https://doi.org/10.1016/J.FORSCIINT.2016.07.005

    Article  CAS  PubMed  Google Scholar 

  8. Fletcher JE, Sebel PS, Murphy MR et al (1991) Comparison of ocfentanil and fentanyl as supplements to general anesthesia. Anesth Analg 73:622–626

    CAS  PubMed  Google Scholar 

  9. Misailidi N, Papoutsis I, Nikolaou P et al (2018) Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil. Forensic Toxicol 36:12–32. https://doi.org/10.1007/s11419-017-0379-4

    Article  CAS  PubMed  Google Scholar 

  10. Drug Enforcement Administration (2018) Schedules of controlled substances: temporary placement of seven fentanyl-related substances in schedule I. temporary amendment; temporary scheduling order. Fed Regist 83:4580–4585

    Google Scholar 

  11. Canadian Centre on Substance Abuse (2016) Novel synthetic opioids in counterfeit pharmaceuticals and other illicit street drugs. Canadian Community Epidemiology Network on Drug Use, Ottawa

    Google Scholar 

  12. Prekupec MP, Mansky PA, Baumann MH (2017) Misuse of novel synthetic opioids: a deadly new trend. J Addict Med 11:256–265. https://doi.org/10.1097/ADM.0000000000000324

    Article  PubMed  PubMed Central  Google Scholar 

  13. Huang X-P, Che T, Mangano TJ et al (2017) Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity in vitro and in vivo. JCI Insight 2:e97222. https://doi.org/10.1172/jci.insight.97222

    Article  PubMed Central  Google Scholar 

  14. Cannaert A, Stove C (2018) Personal mail communication: W-18 receptor binding activity

  15. Cannaert A, Vasudevan L, Friscia M et al (2018) Activity-based concept to screen biological matrices for opiates and (synthetic) opioids. Clin Chem 64:1221–1229. https://doi.org/10.1373/clinchem.2018.289496

    Article  CAS  PubMed  Google Scholar 

  16. Cayman Chemical (2012) Cayman Spectral Library. In: Online database. https://www.caymanchem.com/forensic/csl/?q=*%3A*. Accessed 17 Jul 2018

  17. Dussy FE, Hangartner S, Hamberg C et al (2016) An acute ocfentanil fatality: a case report with postmortem concentrations. J Anal Toxicol 40:761–766. https://doi.org/10.1093/jat/bkw096

    Article  CAS  PubMed  Google Scholar 

  18. Marchard A, Martin-Molins C, Moal A et al (2017) L’ocfentanil: un bon exemple des dangers des NPS (new psychoactive substances). Toxicol Anal Clin 29:S63. https://doi.org/10.1016/J.TOXAC.2017.03.091

    Article  Google Scholar 

  19. Graddy R, Buresh ME, Rastegar DA (2018) New and emerging illicit psychoactive substances. Med Clin North Am 102:697–714. https://doi.org/10.1016/J.MCNA.2018.02.010

    Article  PubMed  Google Scholar 

  20. Stanley TH (2014) The fentanyl story. J Pain 15:1215–1226. https://doi.org/10.1016/J.JPAIN.2014.08.010

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Tessa Windelinckx (Free Clinic vzw, Schijnpoortweg 14, 2060 Antwerp, Belgium) for providing the sample.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Maarten Degreef or Kristof E. Maudens.

Ethics declarations

Conflict of interest

Alexander van Nuijs received a postdoctoral scholarship from the Research Foundation Flanders (FWO, Grant no. 1285216N).

Ethical standards

This article does not contain any studies involving living human participants or animals, performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 370 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Degreef, M., Blanckaert, P., Berry, E.M. et al. Determination of ocfentanil and W-18 in a suspicious heroin-like powder in Belgium. Forensic Toxicol 37, 474–479 (2019). https://doi.org/10.1007/s11419-019-00480-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11419-019-00480-3

Keywords

Navigation